Followers | 1102 |
Posts | 27890 |
Boards Moderated | 10 |
Alias Born | 01/11/2016 |
Tuesday, March 03, 2020 11:15:19 PM
Here is the reason why: Number one reason: Because I like to and if it bothers you don't read them
Number two reason: IHUB has the BOLD link there for a reason, just like God gave us tongues and this Country has given every individual the right to Freedom of Press/Speech
Number three reason: I am confident about what I post that is why I post in BOLD.
Have you ever seen a shrink? when you tell a shrink what annoys you, what do they tell you? They tell you to stay away from environment that annoy you.
Yes and yes, MRNA is in the forefront in developing this vaccine and I am not here for the vaccine, I am here for the rest of the drug pipeline, we should at least get 3-4 data by year end.
Good luck and if my BOLD post annoys you, please don't read them.
Recent MRNA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2024 09:14:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 02:27:29 PM
- Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma • PR Newswire (US) • 11/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:03:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 11:33:51 AM
- U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop • IH Market News • 11/07/2024 11:19:35 AM
- Trump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time High • IH Market News • 11/06/2024 11:09:49 AM
- Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 • PR Newswire (US) • 11/05/2024 02:05:00 PM
- Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC) • Business Wire • 10/28/2024 10:45:00 AM
- Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence • PR Newswire (US) • 10/23/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/08/2024 08:19:25 PM
- Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA • PR Newswire (US) • 10/07/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:52:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 12:49:56 PM
- Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors • PR Newswire (US) • 10/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 11:03:59 AM
- The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 09/30/2024 09:45:00 AM
- Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 09/26/2024 09:45:00 AM
- Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA • PR Newswire (US) • 09/23/2024 09:45:00 AM
- The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA • PR Newswire (US) • 09/19/2024 09:45:00 AM
- The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 09/16/2024 09:45:00 AM
- OpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth Forecast • IH Market News • 09/13/2024 10:12:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 10:03:14 AM
- Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA • PR Newswire (US) • 09/12/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:15:27 PM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM